Stay updated with breaking news from Ryan Weispfenning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for 4,120 individuals on the...
Medtronic Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Announces 9% Dividend Increase - Q4 Revenue of $8.2 Billion Increased 37% Reported and 32% Organic - Q4 GAAP Diluted EPS of $1.00; Q4 Non-GAAP Diluted EPS of $1.50 - Quarterly Dividend Increased to $0.63, Annual $2.52 from Prior $2.32; 44th Consecutive Year of Dividend Increases - Company Issues FY22 Guidance - Guidance Reflects FY22 Revenue Growth above Street Consensus, Investment Ahead of Major Product Launches, and Largest Planned R&D Increase in Company History News provided by Share this article Share this article ...
MDT earnings call for the period ending April 30, 2021.
New No Fingerstick 1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System Medtronic plc the global leader in medical technology, today announced CE Mark for expanded functionality of the company's InPen™ smart 2 insulin pen for multiple daily injections . The company also announced CE Mark for its Guardian™ 4 sensor 3 which requires no fingersticks 1 for calibration or diabetes ...
/PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming...